Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × vinflunine × Clear all

Phase

Status

Completed 24 Withdrawn 2 Terminated 2 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Cisplatin 111 Carboplatin 109 Drug Therapy 94 Oxaliplatin 91 Capecitabine 86 Bevacizumab 83 Paclitaxel 80 pembrolizumab 76 Radiotherapy 76 Gemcitabine 76 Cyclophosphamide 76 tislelizumab 72 Specimen Handling 60 Fluorouracil 57 toripalimab 56 Injections 52 sintilimab 50 Docetaxel 48 Magnetic Resonance Spectroscopy 47 130-nm albumin-bound paclitaxel 45 Surgical Procedures, Operative 42 Leucovorin 40 Biopsy 40 fludarabine 38 anlotinib 37 Pemetrexed 37 Standard of Care 36 Radiosurgery 35 lenvatinib 34 Irinotecan 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07419295 2026-02-19

TroFuse-031

Merck Sharp & Dohme LLC

Phase 3 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡